Charles River Laboratories International (CRL) Change in Accured Expenses (2009 - 2026)

Charles River Laboratories International has reported Change in Accured Expenses for 18 years, with the latest figure at $18.9 million in Q2 2026.

• On a quarterly basis, Change in Accured Expenses fell 20.34% year-over-year to $18.9 million in Q2 2026; TTM through Jun 2026 was -$24.5 million, a 155.1% decrease from a year earlier, with the FY2025 full-year figure at $79.3 million, up 387.31% from the prior year.
• Change in Accured Expenses was $18.9 million for Q2 2026 at Charles River Laboratories International, up from -$83.8 million in the prior quarter.
• The five-year high for Change in Accured Expenses was $42.9 million in Q3 2025, with the low at -$83.8 million in Q1 2026.
• Average Change in Accured Expenses over 5 years is -$2.4 million, with a median of $1.4 million recorded in 2022.
• The sharpest annual moves came in 2023 and 2026: Change in Accured Expenses soared 563.47% in 2023, then slumped 648.76% in 2026.
• Over 5 years, Change in Accured Expenses stood at -$9.4 million in 2022, then sank by 69.58% to -$16.0 million in 2023, then tumbled by 60.23% to -$25.6 million in 2024, then soared by 90.0% to -$2.6 million in 2025, then surged by 837.7% to $18.9 million in 2026.
• The last three Change in Accured Expenses figures came in at $18.9 million (Q2 2026), -$83.8 million (Q1 2026), and -$2.6 million (Q4 2025), per Business Quant data.